{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:11:23Z","timestamp":1789726283095,"version":"4.0.1"},"reference-count":12,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T00:00:00Z","timestamp":1205712000000},"content-version":"vor","delay-in-days":4124,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[1996,12]]},"abstract":"<jats:p>Abstract A case of repetitive hallucinations during treatment with a therapeutic dosage of triazolam (0.25 mg\/day) and nitrazepam (5 mg\/day) is presented. The patient suffered from acute pneumonia and chronic renal failure. Such non\u2010psychotic symptoms as anxiety, tremor and depressed feeling were observed initially. However, after co\u2010administration of erythromycin (600 mg\/day), visual hallucinations and abnormal bodily sensations developed repeatedly after each administration of triazolam or nitrazepam. This report suggests that benzodiazepine hypnotics even at a therapeutic dosage with co\u2010administration of erythromycin causes serious psychotic symptoms in vulnerable patients with physical complications.<\/jats:p>","DOI":"10.1111\/j.1440-1819.1996.tb00577.x","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T14:23:31Z","timestamp":1205763811000},"page":"337-339","source":"Crossref","is-referenced-by-count":10,"title":["Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co\u2010administration of erythromycin"],"prefix":"10.1111","volume":"50","author":[{"given":"NOBORU","family":"TOKINAGA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TSUYOSHI","family":"KONDO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUNAO","family":"KANEKO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOICHI","family":"OTANI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUO","family":"MIHARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHIGERU","family":"MORITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,3,17]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"345","volume-title":"The Pharmacological Basis of Therapeutics","author":"Rail TW","year":"1990"},{"key":"e_1_2_1_3_2","first-page":"156","article-title":"Het Halcion\u2010syndroom \u2013 een iatrogene epdi\u2010emie in Nederland","volume":"8","author":"Van der Kroef C.","year":"1982","journal-title":"T. Ale. Drugs."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014592"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92524-6"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198325040-00003"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.157.1.154"},{"key":"e_1_2_1_8_2","first-page":"267","article-title":"Does the co\u2010administration of antidepressants facilitate the development of benzodiazepine withdrawal psychosis","volume":"5","author":"Mihara K.","year":"1993","journal-title":"J Drug Dev."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02725.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198610000-00008"},{"key":"e_1_2_1_11_2","first-page":"89","article-title":"Oxidation of midazolam and triazolam by human liver cytochrome P450 3A4","volume":"36","author":"Kronbach T.","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(83)90626-3"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00543975"}],"container-title":["Psychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1819.1996.tb00577.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1819.1996.tb00577.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T17:50:25Z","timestamp":1698429025000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1819.1996.tb00577.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,12]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1996,12]]}},"alternative-id":["10.1111\/j.1440-1819.1996.tb00577.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1819.1996.tb00577.x","archive":["Portico"],"relation":{},"ISSN":["1323-1316","1440-1819"],"issn-type":[{"value":"1323-1316","type":"print"},{"value":"1440-1819","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,12]]}}}